Justin Letendre

Company: Strand Therapeutics Inc.
Job title: Scientist, Synthetic Biology
Seminars:
STX-003: mRNA-based Cancer Therapy for Tumor-Specific Expression of IL-12 via Programmable Genetic Circuits 4:00 pm
• STX-003 is a systemically delivered immune oncology drug targeting solid tumors and metastatic disease • Programmable sensors embedded in STX-003 allow for cell-selective expression • Engineered control using these sensors improves STX-003 tolerability without compromising efficacy in pre-clinical animal modelsRead more
day: Conference Day Two